InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: Fireman02360 post# 140548

Saturday, 02/10/2018 2:42:49 PM

Saturday, February 10, 2018 2:42:49 PM

Post# of 468747
“In consideration of the new genomic results, the investigational new drug application IND filing for ANAVEX2-73 for the treatment of Rett syndrome will be updated and submitted during the current quarter to include this data. “

(Bolding mine)

Anavex's (AVXL) CEO Christopher Missling on Q1 2018 Results - Earnings Call Transcript $AVXLhttp://www.seekingalpha.com/article/4144319
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News